Articles

Original Articles

How Much Digital Rectal Examination is Valuable for the Decision of Biopsy in Patients with PSA ≤4 ng/ml?

Özgü Aydoğdu
İbrahim Halil Bozkurt
Tarık Yonguç
Tansu Değirmenci
Salih Polat
Bülent Günlüsoy
İbrahim Küçüktürkmen
Yasin Ceylan
Süleyman Minareci

Bull Urooncol 2015; 14: 1-4 DOI: 10.4274/uob.253

Is Prostate Specific Antigen Density more Important than in the Diagnosis of Prostate Cancer in Patients with a Total Prostate Specific Antigen Value <10 ng/mL?

Soner Çoban
Muhammet Güzelsoy
Ali Rıza Türkoğlu
Ünal Kurtoğlu
Dursun Ünal
Noyan Can Akdur
Sedat Öner
Murat Demirbaş

Bull Urooncol 2015; 14: 83-87 DOI: 10.4274/uob.268

Role of Prostate Specific Antigen Density for the Prediction of Radical Therapy Requirement in Localized Prostate Cancer

Ozan Bozkurt
Kaan Çömez
Özgür Gürboğa
Ömer Demir
Güven Aslan
Adil Esen

Bull Urooncol 2016; 15: 103-106 DOI: 10.4274/uob.701

Review

PSA: past, today and tomorrow

Levent Mert Günay
Sertaç Yazıcı
Haluk Özen

Bull Urooncol 2011; 10: 5-10

Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer

Tayyar Alp Özkan
Özdal Dillioğlugil

Bull Urooncol 2014; 13: 41-45

Algorithmic approach to rising PSA after curative prostate cancer treatment

Levent Mert Günay
Şevket Tolga Tombul
Bülent Akdoğan

Bull Urooncol 2011; 10: 51-55

Is prostate cancer be screened according to Turkey data?

Rahmi Gökhan Ekin
Ferruh Zorlu

Bull Urooncol 2013; 12: 71-75

Literature Review

Thomas Stamey

Bull Urooncol 2004; 3: 20-22

Article - Comment

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening

Sinan Ekici

Bull Urooncol 2006; 5: 27-29

Saadettin Yilmaz Eskiçorapçi

Bull Urooncol 2006; 5: 33-34

Bph

The current status of prostate-specific antigen in the management of Benign Prostatic Hyperplasia

Ali Tekin

Bull Urooncol 2013; 12: 232-236

1
2

About Journal

Forms

Useful Links

Applications

Latest Update: 24.08.2020